The day GU oncologists decided to go to the thoracic committee to show our support for ⁦⁦Suzanne Cole, MD, FACP, FASCO⁩ real world trial. ⁦Real world data for real world patients ⁦Hamid Emamekhoo⁩ ⁦ECOG-ACRIN Cancer Research Group⁩ ⁦⁦UMass Cancer Center⁩

Real World Data Working Group 11/8/24 ECOG-ACRIN Cancer Research Group Fall Meeting - Suzanne Cole, MD, FACP, FASCO #lcsm #PrecisionMedicine #RWD PrE1702

PrE1702 study chair Suzanne Cole, MD, FACP, FASCO explains why our new #RealWoldData #RegistryStudy is so important at the ECOG-ACRIN Cancer Research Group Fall 2024 Group Meeting. Learn more: bit.ly/pre1702

Fantastic ECOG-ACRIN Cancer Research Group meeting with stellar colleagues with ideas for novel trials & real world data! Suzanne Cole, MD, FACP, FASCO KMittaloncMD Hamid Emamekhoo MJ Naomi Haas Kristen Spencer Dustin Deming Mehmet Asim Bilen,MD Elizabeth Plimack MD Balazs Halmos Joseph A. Sparano, MD Amer Zeidan MBBS,MHS ‏عامر زيدان Nataliya Uboha Heather Wakelee

Congratulations to Dr. E Mittendorf and new Board members Soni Smith MD and Melissa Dillmon, and Nominating Cmt members Erika Hamilton, MD, FASCO Suzanne Cole, MD, FACP, FASCO and Rana McKay! So excited to join the ASCO Board with such a great group and a huge thank you to all who supported me!

Congratulations, Dr. E Mittendorf, Nathan A. Pennell MD, PhD, FASCO, Erika Hamilton, MD, FASCO, Soni Smith MD, and all others elected! Especially proud of Suzanne Cole, MD, FACP, FASCO & Rana McKay, MD, FASCO, who have been consistently exceptional leaders and aspirational role models to many of us in GU Oncology! ASCO Cleveland Clinic MD

#RealWorldData registry study PrE1702, led by Suzanne Cole, MD, FACP, FASCO of UTSW Simmons Cancer Center, aims to discover if osimertinib +/- chemotherapy has the same benefits for patients receiving treatment outside of a #ClinicalTrial as for those in a trial. Learn more: bit.ly/pre1702-study

#SOAR is an important trial for oligomet radiation in #kidneycancer, led by our wonderful UTSW Simmons Cancer Center colleagues Suzanne Cole, MD, FACP, FASCO Raquibul Hannan ASCO #GU25

Thanks to Suzanne Cole, MD, FACP, FASCO of UTSouthwestern.org for interviewing with me for OncoDaily’s podcast - #EMPOWERINGONCOLOGISTS ✅Great insights as to how you established a research infrastructure in a community setting. ✅how you navigated through life making choices that were not the

Fantastic to see colleagues & friends Amer. Urol. Assn. discussing science, patient care, research & beyond! Ashish M. Kamat, MD, MBBS Jonathan Rosenberg MD Jean Hoffman-Censits DrBagrodia Bárbara Melão, MD, PhD Sia Daneshmand, M.D. Joshua Meeks Suzanne Cole, MD, FACP, FASCO Sarah P. Psutka MD MS Yaw Nyame Daniel Lin Roger Li Shilpa Gupta Viraj Master

Thanks Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) Suzanne Cole, MD, FACP, FASCO for your support and being amazing collaborators in this trial! #teamscience

#RealWorldData research study PrE1702, led by Suzanne Cole, MD, FACP, FASCO of UTSW Simmons Cancer Center, aims to discover if osimertinib +/- chemotherapy has the same benefits for patients receiving treatment outside of a #ClinicalTrial as for those in a trial. Learn more: bit.ly/pre1702-study

📣We're looking forward to Best of ASCO® Dallas with planning committee member Dr. Suzanne Cole, MD, FACP, FASCO (of UTSW Simmons Cancer Center)! Join us for this Official Annual Meeting Review of the American Society of Clinical Oncology® (ASCO®) - this August 2-3rd. 🌐 REGISTER TODAY:

Spread the word! KMittaloncMD Mazie Tsang, MD, MAS, MS Deepika Devuni MD Vera Kazakova Oncology Brothers Tulsi Jose, MD Suzanne Cole, MD, FACP, FASCO

Beyond excited to present the results of our investigator-initiated #CLONEVO trial at #ASCO25 ASCO! 🏢Arie Crown Theater on May 31, 2025 🕐 Only 4 weeks of pre-op abemaciclib in patients with cisplatin-ineligible MIBC resulted in: ✅ 31% pathologic downstaging ✅ Clear

#ASCO25 Amazing to be able to start ASCO Day 1 with families and friends (who are like family)- ✅we presented the KAMBOJ-CHRISTIE Family & friends and MSCO BOARD YIA Award ✅shared my story with the IMG CoP ✅got the Yvonne Award for community oncology by OncoDaily

🗣️Bladder Rapid Oral Abstracts #ASCO25 👉Abs4520: Dr Dr. Bishoy M. Faltas presenting #abemaciclib cis-ineligible MIBC on #CLONEVO 🩺Clinical implications: - Preoperative #abemaciclib in MIBC demonstrated promising efficacy and tolerability while modulating cell cycle-dependent pathways

Congratulations to ⁦KMittaloncMD⁩ and team for delivering her talk in the symptom management track #ASCO25 ⁦Petros Grivas⁩ ⁦Suzanne Cole, MD, FACP, FASCO⁩

MJ Petros Grivas Suzanne Cole, MD, FACP, FASCO 🙏 MJ As immunotherapies expand their presence, and as we develop novel combinations through our ECOG GU committee, building teams for #irAE management in the real world is critical!

Surgical outcomes of radical nephrectomy and inferior vena cava thrombectomy following preoperative systemic immunotherapy: a propensity score analysis. #AuthorCommentary on UroToday > bit.ly/3Yazt6U Zine-Eddine Khene Raj Bhanvadia Wadih Issa, MD Solomon Woldu Kris Gaston, MD, FACS Hans Hammers